Green Plains Inc.: financial analysis
Ratios worked out from 10 fiscal years of Green Plains Inc.'s statements, compared with 94 companies in Chemicals.
Green Plains Inc. scorecard#
Passes 10 of the 25 checks that could be worked out: strongest in valuation (5 of 5), weakest in growth (0 of 6). Fiscal year 2025; market cap of Oct 28, 2026.
Valuation5 of 5
- ✓P/E below its peers' median4.8×P/E 4.8× against Chemicals's median of 23.1×.
- ✓Price to book below its peers' median1.2×Price to book 1.2× against Chemicals's median of 2.1×.
- ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Chemicals's median of 1.8×.
- ✓Free cash flow yield above 5%7.7%Free cash flow is 7.7% of the market value.
- ✓Earnings yield above the 10-year Treasury yield20.7%Earnings yield 20.7% against the 10-year Treasury's 4.92% on 2026-11-20.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth0 of 6
- ✗Revenue grew in the newest year-14.9%Revenue down 14.9% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years-17.0%-17.0% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median-17.0%-17.0% a year against Chemicals's median of -2.9% (60 companies).
- ✗Earnings per share grew in the newest year-1.80 vs -1.29Diluted EPS -1.80 in fiscal 2025 against -1.29 the year before (report's currency).
- ✗Net income higher than five years earlier-$121 M-$121 M in fiscal 2025 against -$109 M in 2020.
- ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
Profitability0 of 5
- ✗Profitable in the newest year-$121 MNet income -$121 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-3.2%-3.2% against Chemicals's median of 4.4% (73 companies).
- ✗Return on equity above 15%-14.9%-14.9% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-3.2%-3.2% in fiscal 2025 against -2.7% in 2022.
Financial health2 of 5
- ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.94 at the end of fiscal 2025.
- ✓Debt below equity0.5×Debt to equity 0.49 at the end of fiscal 2025.
- ✗Net debt below three years of EBITDA6.2×Net debt 6.2 times EBITDA in fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone1.69Z-score 1.69 (distress zone) for fiscal 2025.
Shareholder returns3 of 4
- ✓Pays a dividendYesPaid dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomeNo payout ratio (a loss year).
- ✗Share count up no more than 2% in a year5.8%Diluted shares up 5.8% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.2%Dividends and buybacks were 3.2% of the market value.
- ✓Free cash flow covers dividends and buybacks$74 MFree cash flow $74 M against $31 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Chemicals, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Worth a look
- Revenue fell 14.9% against the year before.
- Net loss of $121 million, the 7th loss-making year in a row.
- The share count rose 5.8% in the year.
- Net debt is 6.2 times a year's operating earnings before depreciation.
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profitno
- Operations brought in cashyes
- Return on assets roseno
- Cash from operations exceeds profityes
- Long-term debt fell against assetsyes
- Current ratio roseyes
- No new shares issuedno
- Gross margin roseyes
- Asset turnover roseno
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | 0.16 | × 1.2 | 0.19 |
| Retained earnings to assets | -0.28 | × 1.4 | -0.39 |
| Operating income to assets | -0.04 | × 3.3 | -0.14 |
| Market value to liabilities | 1.17 | × 0.6 | 0.70 |
| Revenue to assets | 1.32 | × 1 | 1.32 |
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 6.6% | 5.3% | 5.0% | 3.1% | 7.2% | 29.8% | 9% | |
| Operating margin | -3.2% | -1.9% | -1.9% | -2.7% | 0.9% | 4.4% | 29% | |
| Net margin | -5.8% | -3.4% | -2.8% | -3.5% | -2.3% | 2.1% | 31% | |
| Return on equity | -14.9% | -9.7% | -10.7% | -13.7% | -8.3% | 1.9% | 22% | |
| Return on assets | -7.2% | -4.4% | -4.6% | -5.9% | -3.5% | 0.8% | 21% | |
| Return on invested capital | — | — | — | — | — | 8.9% | — |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | -14.9% | -25.4% | -10.0% | 29.6% | 47.0% | -0.8% | 11% | |
| Revenue growth, 3 years a year | -17.0% | -4.6% | 19.7% | 14.9% | -1.8% | -2.9% | 8% | |
| Revenue growth, 5 years a year | 1.7% | 0.3% | 2.0% | 2.2% | -3.7% | 5.2% | 23% | |
| Net income growth | — | — | — | — | — | -4.2% | — | |
| Earnings per share growth | — | — | — | — | — | -3.4% | — |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | 0.49× | 0.51× | 0.59× | 0.55× | 0.59× | 0.64× | 75% | |
| Net debt | $192 M | $265 M | $149 M | $59 M | $133 M | $862 M | 82% | |
| Net debt to EBITDA | 6.16× | 6.14× | 4.07× | — | 1.13× | 2.77× | 19% | |
| Interest cover | — | — | -1.63× | -3.03× | 0.38× | 1.18× | — | |
| Current ratio | 1.94× | 1.48× | 1.90× | 1.91× | 2.37× | 2.22× | 42% | |
| Equity share of assets | 48.4% | 48.6% | 43.5% | 42.9% | 44.0% | 48.9% | 47% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $74 M | $-125 M | $-52 M | $-143 M | $-183 M | $51 M | 57% | |
| Free cash flow margin | 3.5% | -5.1% | -1.6% | -3.9% | -6.5% | 3.6% | 49% | |
| Cash conversion | — | — | — | — | — | 175.2% | — | |
| Capital spending share of revenue | 1.8% | 3.9% | 3.3% | 5.8% | 6.6% | 5.0% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 1.24× | 1.32× | 1.62× | 1.71× | 1.51× | 0.69× | 92% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Dividend yield
- Dividends paid in the fiscal year as a share of today's market value.
- Buyback yield
- Shares bought back in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Dividend payout
- Dividends paid as a share of net income. Only when the year was profitable.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).